Inspire Medical Systems, Inc. (FRA:2DR)

Inspire Medical Systems Statistics

Total Valuation

FRA:2DR has a market cap or net worth of EUR 1.44 billion. The enterprise value is 1.21 billion.

Market Cap	1.44B
Enterprise Value	1.21B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	28.59M
Shares Outstanding	n/a
Shares Change (YoY)	-2.57%
Shares Change (QoQ)	-1.29%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	26.70M

Valuation Ratios

The trailing PE ratio is 11.66 and the forward PE ratio is 28.23.

PE Ratio	11.66
Forward PE	28.23
PS Ratio	1.86
PB Ratio	2.17
P/TBV Ratio	2.17
P/FCF Ratio	21.61
P/OCF Ratio	14.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.03, with an EV/FCF ratio of 18.11.

EV / Earnings	9.77
EV / Sales	1.56
EV / EBITDA	20.03
EV / EBIT	27.98
EV / FCF	18.11

Financial Position

The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.04.

Current Ratio	6.08
Quick Ratio	4.46
Debt / Equity	0.04
Debt / EBITDA	0.45
Debt / FCF	0.41
Interest Coverage	371.93

Financial Efficiency

Return on equity (ROE) is 19.77% and return on invested capital (ROIC) is 11.56%.

Return on Equity (ROE)	19.77%
Return on Assets (ROA)	3.71%
Return on Invested Capital (ROIC)	11.56%
Return on Capital Employed (ROCE)	6.28%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	582,696
Profits Per Employee	92,915
Employee Count	1,333
Asset Turnover	1.06
Inventory Turnover	1.18

Taxes

Income Tax	-67.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-70.55%
50-Day Moving Average	75.67
200-Day Moving Average	87.02
Relative Strength Index (RSI)	32.04
Average Volume (20 Days)	4

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.29

Income Statement

In the last 12 months, FRA:2DR had revenue of EUR 776.73 million and earned 123.86 million in profits. Earnings per share was 4.16.

Revenue	776.73M
Gross Profit	663.27M
Operating Income	43.40M
Pretax Income	55.95M
Net Income	123.86M
EBITDA	55.28M
EBIT	43.40M
Earnings Per Share (EPS)	4.16

Balance Sheet

The company has 262.55 million in cash and 27.39 million in debt, with a net cash position of 235.17 million.

Cash & Cash Equivalents	262.55M
Total Debt	27.39M
Net Cash	235.17M
Net Cash Per Share	n/a
Equity (Book Value)	665.31M
Book Value Per Share	23.28
Working Capital	415.29M

Cash Flow

In the last 12 months, operating cash flow was 99.63 million and capital expenditures -32.79 million, giving a free cash flow of 66.84 million.

Operating Cash Flow	99.63M
Capital Expenditures	-32.79M
Free Cash Flow	66.84M
FCF Per Share	n/a

Margins

Gross margin is 85.39%, with operating and profit margins of 5.59% and 15.95%.

Gross Margin	85.39%
Operating Margin	5.59%
Pretax Margin	7.20%
Profit Margin	15.95%
EBITDA Margin	7.12%
EBIT Margin	5.59%
FCF Margin	8.61%

Dividends & Yields

FRA:2DR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.57%
Shareholder Yield	2.57%
Earnings Yield	8.57%
FCF Yield	4.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:2DR has an Altman Z-Score of 19.87 and a Piotroski F-Score of 4.

Altman Z-Score	19.87
Piotroski F-Score	4